Nuclear Medicine Technology. Progress Report for Quarter Ending September 30, 1978 (open access)

Nuclear Medicine Technology. Progress Report for Quarter Ending September 30, 1978

A unique class of radiopharmaceuticals labeled with the /sup 117m/Sn nuclide has been developed. The attractive properties of /sup 117m/Sn include a 14-day physical half-life and the emission of a single ..gamma..-photon with an optimal energy of 159 keV. A specialized apparatus was designed for the conversion of metallic /sup 117m/Sn to /sup 117m/SnCl/sub 4/ which was subsequently converted to a variety of useful /sup 117m/Sn-labeled organotin intermediates. The availability of this unique approach will now make possible the synthesis of a wide variety of /sup 117m/Sn-labeled compounds of biological interest. Such tissue-specific /sup 117m/Sn-labeled agents may represent a new class of useful radiopharmaceuticals. Continuing studies involving the preparation and testing of radiopharmaceuticals labeled with /sup 11/C, /sup 195m/Pt, and /sup 75/Se are also described. Several /sup 11/C-labeled amino acids including /sup 11/C-DL-tryptophan, /sup 11/C-1-aminocyclobutanecarboxylic acid (ACBC), and /sup 11/C-1-aminocyclopentanecarboxylic acid (ACPC) were prepared, and patient studies have demonstrated ACBC to be superior to ACPC for tumor localization. Studies with /sup 195m/Pt have recently been directed toward attempting to prepare high specific activity /sup 195m/Pt by the Szilard--Chalmers process. Progress is also reported in the development of an in vivo diffusion chamber assay technique that is being used to investigate …
Date: February 1, 1979
Creator: Knapp, Furn F., Jr.
System: The UNT Digital Library
Nuclear Medicine Technology Progress Report for Quarter Ending June 30, 1978. (open access)

Nuclear Medicine Technology Progress Report for Quarter Ending June 30, 1978.

Progress is reported for the applications of /sup 11/C, /sup 195m/Pt, /sup 75/Se, and /sup 123m/Te. Additional human clinical trials with /sup 11/C-DL-tryptophan and /sup 11/C-l-aminocyclobutane carboxylic acid have been completed. The modified Buecherer-Strecker amino acid synthesis has been used to prepare /sup 11/C-DL-phenylglycine and /sup 11/C-DL-phenylalanine. These two new /sup 11/C-labeled amino acids will be studied as potential tumor localizing agents. Preliminary studies concerning the comparative organ and subcellular distribution of /sup 195m/Pt-labeled cis- and trans- dichlorodiamineplatinum(II) have been completed. The results of in vivo studies have shown the cis isomer to bind to nuclear DNA to a significantly greater extent than the trans isomer. A series of /sup 123m/Te-labeled long-chain fatty acid analogs have been prepared as isosteres of unsaturated fatty acids. Several of these compounds show pronounced heart uptake in rats and may represent a new class of potential myocardial imaging agents. Studies on the preparation and tissue distribution of /sup 75/Se-..beta..-aminoethyl selenosulfate continue.
Date: December 1, 1978
Creator: Knapp, Furn F., Jr.
System: The UNT Digital Library